Organ-on-a-Chip Device Market to Reach $7.12 Billion by 2032 with 18.5% CAGR The Organ-on-a-Chip Device market has become a pivotal segment of the biotechnology and pharmaceutical industries, providing advanced alternatives for drug testing and disease modeling. In 2024, global revenues are estimated at USD 2.45 billion, up from USD 2.05 billion in 2023, reflecting a 19.5% year-over-year growth. Analysts project the market will expand at a 18.5% Compound Annual Growth Rate (CAGR) from 2025 to 2032, reaching USD 7.12 billion, driven by rising R&D investments and adoption in personalized medicine. Read Full Research Study: https://marketintelo.com/report/organ-on-a-chip-device-market